STACI JOHNSTON: Open Payments
NPI 1104391044 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 30 payments from 9 companies in 2025. Trend: 2023 $965 · 2024 $1,345 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $231 |
| Madrigal Pharmaceuticals | 2 | $188 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $181 |
| Janssen Biotech, Inc. | 2 | $54 |
| PFIZER INC. | 3 | $50 |
| GENZYME CORPORATION | 2 | $41 |
| Celltrion USA Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: REZDIFFRA, XIFAXAN, CREON, RINVOQ, TREMFYA, VELSIPITY, DUPIXENT, VEGZELMA.
Industry payments across PA — which companies pay providers there.
